Objectives: To determine the effect of flexible cystoscopy on the total, free, and percent-free prostate-specific antigen (PSA) values in male volunteers. Flexible cystoscopy is the standard method of evaluation of the bladder and urethra. PSA measurement is currently used in conjunction with the digital rectal examination to detect and guide management of prostate cancer. Thus, we must understand the effect of flexible cystoscopy on serum PSA levels.
Methods: Healthy men who were undergoing flexible cystoscopy and provided informed consent were enrolled in the study. The volunteers had blood taken for PSA measurement before cystoscopy and 1 and 24 hours after. The mean PSA values were compared using the paired t test.
Results: A total of 40 volunteers (age 22-82 years) enrolled in the study. Statistically significant increases in the total, free, and percent-free PSA values were noted at 1 and 24 hours after cystoscopy. The differences of 0.113 and 0.112 ng/mL (P < .05) in the mean total PSA level at 1 and 24 hours after cystoscopy were not clinically significant. The interassay variability was 0.053 ng/mL, with a standard deviation of 0.150 ng/mL. The standard deviation of 0150 ng/mL was greater than the 0.113- and 0.112-ng/mL differences seen in the total PSA values at 1 and 24 hours after cystoscopy.
Conclusions: Statistically significant differences were noted in the total, free, and percent-free PSA levels before and after cystoscopy. Although these small differences achieved statistical significance, none were clinically significant. We have concluded that the serum PSA values are not affected by diagnostic flexible cystoscopy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.urology.2008.09.011 | DOI Listing |
Investig Clin Urol
January 2025
Department of Spinal Neurosurgery, Gangnam Severance Hospital, Seoul, Korea.
Purpose: This study aims to develop and implement an economic evaluation using a micro-costing approach to provide a precise and transparent analysis of the direct costs of cystoscopic procedures in Korean hospitals. The study seeks to identify key cost components and evaluate whether current reimbursement rates accurately reflect these direct costs.
Materials And Methods: Significant variations in cost items were identified across different studies.
A 55-year-old female attended the Outpatient Urology Department for local anaesthetic flexible cystoscopy and intradetrusor botulinum toxin A injection. Having been diagnosed with urodynamics-proven low-grade detrusor overactivity in 2017, she was well-established on six-monthly Botox® injections. As part of her ongoing treatment, 100 units of Allergan Botox diluted with saline in a 10 mL syringe were injected via 20 punctures.
View Article and Find Full Text PDFBJU Int
November 2024
University Hospital Southampton, Southampton, UK.
Objectives: To investigate patient tolerability and safety (using urinary tract infection (UTI) as a proxy measure) following EndoSheath-assisted flexible cystoscopy (eFC). EndoSheaths are single-use, disposable sheaths used in FC. They reduce cystoscope turnaround times as complicated, time-consuming and costly sterilisation is no longer necessary.
View Article and Find Full Text PDFAnn Ital Chir
October 2024
Department of Urology, Erzurum Regional Training and Research Hospital, University of Health Sciences, 25100 Erzurum, Türkiye.
Ureteropelvic junction (UPJ) obstruction, in addition to causing progressive renal function loss, can lead to the formation of retained stones. Management planning for concomitant stones and UPJ obstruction is a topic of debate in the literature. We performed laparoscopic pyeloplasty and extracted all 144 stones from the renal pelvis and calyces of a 37-year-old male with UPJ stricture, using wireless flexible cystoscopic guidance.
View Article and Find Full Text PDFDiagnostics (Basel)
September 2024
Department of Urology, Sapienza Università di Roma, 00191 Rome, Italy.
The aim of our study is to evaluate the possible urodynamic effect of prostatic urethral lift (PUL) in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. : A consecutive series of patients undergoing PUL placement were consecutively enrolled in two centers. Inclusion criteria: ≥50 years of age, benign prostatic obstruction (BPO), international prostate symptom score (IPSS) ≥ 13, prostate volume ≤ 60 mL, and no middle prostate lobe.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!